![\"\"](\"https:\/\/admixtio.com\/wp-content\/uploads\/2026\/03\/imagen-blog-ADMIXTIO-300x200.webp\")
<\/p>\nFor any company placing ingredients on the European market\u2014whether in detergents, cosmetics, nutrition or specialty chemicals\u2014regulation is not merely an administrative requirement. It is a structural component of the business model.<\/p>\n
The European framework combines several regulatory layers that interact with one another:<\/p>\n
- \n
- \n
Regulation (EC) No 1907\/2006 (REACH)<\/p>\n<\/li>\n
- \n
Regulation (EC) No 1272\/2008 (CLP)<\/p>\n<\/li>\n
- \n
Sector-specific regulations (cosmetics, food, biocides, detergents)<\/p>\n<\/li>\n
- \n
Horizontal rules on fair commercial practices and claim substantiation<\/p>\n<\/li>\n<\/ul>\n
The challenge is rarely the lack of regulatory texts. The real difficulty lies in understanding how regulation affects the technical and commercial positioning of an ingredient<\/strong>.<\/p>\n
Today, compliance alone is not sufficient. What matters is technical and documentary coherence throughout the value chain.<\/p>\n
REACH: More Than a Registration Number<\/h2>\n
REACH requires registration of substances manufactured or imported in quantities \u22651 tonne per year. However, in professional practice the key question is not whether a substance has a registration number, but whether it is properly covered for the intended use<\/strong>.<\/p>\n
Critical aspects to review include:<\/p>\n
- \n
- \n
Exact substance identity (including UVCB substances)<\/p>\n<\/li>\n
- \n
Tonnage band covered by the dossier<\/p>\n<\/li>\n
- \n
Exposure scenarios included in the Chemical Safety Report<\/p>\n<\/li>\n
- \n
Applicable restrictions (Annex XVII)<\/p>\n<\/li>\n
- \n
Inclusion in the Candidate List (SVHC)<\/p>\n<\/li>\n<\/ul>\n
A substance listed as SVHC may still be legally used in many cases, but it fundamentally changes the technical and commercial discussion. It affects risk perception, communication obligations and the strategic decisions of industrial customers.<\/p>\n
From a professional perspective, relying solely on a supplier declaration is not sufficient. Verifying actual use coverage and documentary consistency<\/strong> is essential.<\/p>\n
CLP: Classification, Consistency and Technical Consequences<\/h2>\n
The CLP Regulation establishes classification and labelling rules based on physical, health and environmental hazards.<\/p>\n
When no harmonised classification exists (Annex VI), suppliers must perform self-classification. At this stage, several important issues arise:<\/p>\n
- \n
- \n
Origin and quality of toxicological data<\/p>\n<\/li>\n
- \n
Use of read-across approaches and their scientific justification<\/p>\n<\/li>\n
- \n
Consistency with the ECHA C&L Inventory database<\/p>\n<\/li>\n<\/ul>\n
Minimising hazard classification for commercial reasons is a strategic mistake. Industrial customers with strong regulatory teams quickly detect inconsistencies between suppliers.<\/p>\n
Impact on Formulation<\/h3>\n
Classification is not an isolated regulatory detail. It directly affects:<\/p>\n
- \n
- \n
Maximum concentrations in mixtures<\/p>\n<\/li>\n
- \n
Labelling requirements for finished products<\/p>\n<\/li>\n
- \n
Compatibility with voluntary certifications (e.g. EU Ecolabel)<\/p>\n<\/li>\n
- \n
Market perception of safety<\/p>\n<\/li>\n<\/ul>\n
In detergents or personal care formulations, small classification differences can trigger major reformulation efforts.<\/p>\n
Sector-Specific Regulation: Context Matters<\/h2>\n
An ingredient may be fully compliant with REACH and CLP yet still be unsuitable for certain sectors.<\/p>\n
Cosmetics<\/h3>\n
Regulation (EC) No 1223\/2009 establishes:<\/p>\n
- \n
- \n
Lists of prohibited and restricted substances<\/p>\n<\/li>\n
- \n
Product safety assessment requirements (CPSR)<\/p>\n<\/li>\n
- \n
Strict rules for claims (Regulation (EU) No 655\/2013)<\/p>\n<\/li>\n<\/ul>\n
CLP classification does not automatically determine cosmetic prohibition, but it strongly influences toxicological evaluation.<\/p>\n
Nutrition<\/h3>\n
In food and dietary supplements, the framework differs significantly:<\/p>\n
- \n
- \n
Regulation (EU) 2015\/2283 on Novel Foods<\/p>\n<\/li>\n
- \n
Regulation (EC) No 1924\/2006 on nutrition and health claims<\/p>\n<\/li>\n
- \n
Scientific evaluations by EFSA<\/p>\n<\/li>\n<\/ul>\n
An ingredient may be technically safe from a chemical perspective but still require specific authorisation before being used in food applications.<\/p>\n
Biocides and Detergents<\/h3>\n
In the biocidal sector, Regulation (EU) No 528\/2012 establishes a system of active substance approval and product authorisation.<\/p>\n
In detergents, Regulation (EC) No 648\/2004 establishes the European rules governing the manufacture, marketing, and labelling of detergents.<\/p>\n
Technical Claims: Evidence, Limits and Responsibility<\/h2>\n
European legislation requires that commercial claims be supported by appropriate evidence.<\/p>\n
In cosmetics, Regulation (EU) No 655\/2013 defines common criteria: truthfulness, evidential support, honesty and fairness.<\/p>\n
In food applications, Regulation (EC) No 1924\/2006 strictly controls health and nutrition claims.<\/p>\n
Directive 2005\/29\/EC on unfair commercial practices acts as a horizontal framework.<\/p>\n
What \u201cAdequate Evidence\u201d Really Means<\/h3>\n
From a technical perspective, adequate evidence requires:<\/p>\n
- \n
- \n
Recognised or scientifically justified methods<\/p>\n<\/li>\n
- \n
Coherent experimental design<\/p>\n<\/li>\n
- \n
Reproducible data<\/p>\n<\/li>\n
- \n
Sound statistical interpretation<\/p>\n<\/li>\n<\/ul>\n
A preliminary in vitro experiment does not justify a quantified performance claim. Confusing exploratory science with commercial proof is one of the most frequent mistakes in technical marketing.<\/p>\n
Industrial customers expect consistency between technical data sheets, safety data sheets, technical literature and commercial messaging.<\/p>\n
Practical Implications for Industry<\/h2>\n
Formulation<\/h3>\n
- \n
- \n
Raw material selection constrained by classification and restrictions<\/p>\n<\/li>\n
- \n
Reformulation when regulatory status changes (e.g. new SVHC listings)<\/p>\n<\/li>\n
- \n
Need to integrate regulatory considerations early in product development<\/p>\n<\/li>\n<\/ul>\n
Regulatory Affairs and Compliance<\/h3>\n
- \n
- \n
Continuous monitoring of regulatory updates<\/p>\n<\/li>\n
- \n
Coordination between regulatory affairs, R&D and marketing teams<\/p>\n<\/li>\n
- \n
Periodic portfolio review<\/p>\n<\/li>\n<\/ul>\n
Technical Marketing<\/h3>\n
- \n
- \n
Arguments based on verifiable technical data<\/p>\n<\/li>\n
- \n
Proportionate and defensible claims<\/p>\n<\/li>\n
- \n
Transparency toward industrial customers<\/p>\n<\/li>\n<\/ul>\n
Weak regulatory strategy does not only create legal risk\u2014it undermines technical credibility.<\/p>\n
Frequent Industry Mistakes<\/h2>\n
Common issues observed in practice include:<\/p>\n
- \n
- \n
Assuming that \u201cREACH registered\u201d automatically means \u201csuitable for any application\u201d<\/p>\n<\/li>\n
- \n
Failing to monitor SVHC status regularly<\/p>\n<\/li>\n
- \n
Using non-validated internal studies as the basis for ambitious claims<\/p>\n<\/li>\n
- \n
Disconnecting technical and commercial teams<\/p>\n<\/li>\n
- \n
Ignoring regulatory updates in safety data sheets<\/p>\n<\/li>\n<\/ul>\n
European regulation is dynamic. The update of Annex II of the SDS requirements through Regulation (EU) 2020\/878 illustrates how regulatory changes can directly impact documentation and compliance obligations.<\/p>\n
Conclusion<\/h2>\n
European chemical regulation is not a bureaucratic obstacle. It is a structured framework that shapes formulation decisions, market positioning and the commercial viability of ingredients.<\/p>\n
REACH provides the foundation for chemical risk management.
CLP defines hazard communication.
Sector-specific legislation determines acceptable uses.
Claim regulations ensure coherence between science and communication.<\/p>\nTechnical expertise does not lie in quoting regulatory articles, but in integrating them into practical decisions: what to develop, how to formulate and what can realistically be claimed.<\/p>\n
In today\u2019s European market, operating successfully requires an integrated perspective where formulation, regulation and technical marketing are aligned from the outset.<\/p>\n
\u00a0<\/h2>\n
References and Web Resources<\/h2>\n
- \n
- \n
Regulation (EC) No 1907\/2006 (REACH)
https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX:32006R1907<\/a><\/p>\n<\/li>\n- \n
Regulation (EC) No 1272\/2008 (CLP)
https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX:32008R1272<\/a><\/p>\n<\/li>\n- \n
European Chemicals Agency (ECHA)
https:\/\/echa.europa.eu<\/a><\/p>\n<\/li>\n- \n
Regulation (EC) No 1223\/2009 on Cosmetic Products
https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX:32009R1223<\/a><\/p>\n<\/li>\n- \n
Regulation (EU) No 655\/2013 on Common Criteria for Cosmetic Claims
https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX:32013R0655<\/a><\/p>\n<\/li>\n- \n
Regulation (EC) No 1924\/2006 on Nutrition and Health Claims
https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX:32006R1924<\/a><\/p>\n<\/li>\n- \n
Regulation (EU) 2015\/2283 on Novel Foods
https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX:32015R2283<\/a><\/p>\n<\/li>\n- \n
Regulation (EU) No 528\/2012 on Biocidal Products
https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX:32012R0528<\/a><\/p>\n<\/li>\n- \n
Regulation (EC) No 648\/2004 on Detergents
https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX:32004R0648<\/a><\/p>\n<\/li>\n- \n
Regulation (EU) 2020\/878 (Update of SDS requirements)
https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX:32020R0878<\/a><\/p>\n<\/li>\n- \n
- \n
- \n
- \n
- \n
- \n
- \n
- \n
- \n
- \n
- \n
- \n
- \n